Rare hereditary diseases can be identified in patients and specific mutations in tumor cells detected—DNA sequencing revolutionized biomedical research decades ago. In recent years, new sequencing methods (next-generation sequencing) in particular have resulted in numerous scientific breakthroughs. In 2020/2021, for example, they enabled the rapid decoding and global monitoring of the SARS-CoV-2 genome.